These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31268467)

  • 21. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.
    Feldman AM; Oren RM; Abraham WT; Boehmer JP; Carson PE; Eichhorn E; Gilbert EM; Kao A; Leier CV; Lowes BD; Mathier MA; McGrew FA; Metra M; Zisman LS; Shakar SF; Krueger SK; Robertson AD; White BG; Gerber MJ; Wold GE; Bristow MR;
    Am Heart J; 2007 Nov; 154(5):861-9. PubMed ID: 17967591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Characteristics and Outcomes of Intravenous Inotropic Therapy in Advanced Heart Failure.
    Hashim T; Sanam K; Revilla-Martinez M; Morgan CJ; Tallaj JA; Pamboukian SV; Loyaga-Rendon RY; George JF; Acharya D
    Circ Heart Fail; 2015 Sep; 8(5):880-6. PubMed ID: 26179184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic Intravenous Inotropic Support as Palliative Therapy and Bridge Therapy for Patients With Advanced Heart Failure: A Single-Center Experience.
    Rao A; Anderson KM; Mohammed S; Hofmeyer M; Gholami SS; Sheikh FH; Rodrigo ME; Crowell NA; Javed H; Gupta S; Hajouli S; Stewart DE; Hamad A; Najjar SS; Groninger H
    J Card Fail; 2021 Sep; 27(9):974-980. PubMed ID: 34153459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus.
    Farmakis D; Agostoni P; Baholli L; Bautin A; Comin-Colet J; Crespo-Leiro MG; Fedele F; García-Pinilla JM; Giannakoulas G; Grigioni F; Gruchała M; Gustafsson F; Harjola VP; Hasin T; Herpain A; Iliodromitis EK; Karason K; Kivikko M; Liaudet L; Ljubas-Maček J; Marini M; Masip J; Mebazaa A; Nikolaou M; Ostadal P; Põder P; Pollesello P; Polyzogopoulou E; Pölzl G; Tschope C; Varpula M; von Lewinski D; Vrtovec B; Yilmaz MB; Zima E; Parissis J
    Int J Cardiol; 2019 Dec; 297():83-90. PubMed ID: 31615650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inotropic agents].
    Yasumura Y
    Nihon Rinsho; 2006 May; 64(5):927-33. PubMed ID: 16689376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inotropes in the management of acute heart failure.
    Petersen JW; Felker GM
    Crit Care Med; 2008 Jan; 36(1 Suppl):S106-11. PubMed ID: 18158469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infections, Arrhythmias, and Hospitalizations on Home Intravenous Inotropic Therapy.
    Acharya D; Sanam K; Revilla-Martinez M; Hashim T; Morgan CJ; Pamboukian SV; Loyaga-Rendon RY; Tallaj JA
    Am J Cardiol; 2016 Mar; 117(6):952-6. PubMed ID: 26810859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulsed inotropic therapy in chronic congestive heart failure: a review of the literature.
    Woods TD; Prisant LM
    Am J Ther; 2000 Nov; 7(6):375-80. PubMed ID: 11304645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure.
    Shakar SF; Abraham WT; Gilbert EM; Robertson AD; Lowes BD; Zisman LS; Ferguson DA; Bristow MR
    J Am Coll Cardiol; 1998 May; 31(6):1336-40. PubMed ID: 9581729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy.
    Sindone AP; Keogh AM; Macdonald PS; McCosker CJ; Kaan AF
    Am Heart J; 1997 Nov; 134(5 Pt 1):889-900. PubMed ID: 9398101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac drugs: new inotropes.
    Kelleher RM
    Crit Care Nurs Clin North Am; 1989 Jun; 1(2):391-7. PubMed ID: 2818883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic inotropic therapy in end-stage heart failure.
    Hauptman PJ; Mikolajczak P; George A; Mohr CJ; Hoover R; Swindle J; Schnitzler MA
    Am Heart J; 2006 Dec; 152(6):1096.e1-8. PubMed ID: 17161059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermittent positive inotrope infusion in the management of end-stage, low-output heart failure.
    Levine BS
    J Cardiovasc Nurs; 2000 Jul; 14(4):76-93. PubMed ID: 10902105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "I Just Feel Like I Always Did": Inotropic Dependency at End of Life.
    Latimer A; Pope ND; McFarlin JM
    Am J Hosp Palliat Care; 2020 Jul; 37(7):497-502. PubMed ID: 31714150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing inotrope therapy noninvasively.
    Lasater M
    AACN Clin Issues; 1999 Aug; 10(3):406-13. PubMed ID: 10745710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The new concept of ''interventional heart failure therapy'': part 2--inotropes, valvular disease, pumps, and transplantation.
    Thompson KA; Philip KJ; Simsir S; Schwarz ER
    J Cardiovasc Pharmacol Ther; 2010 Sep; 15(3):231-43. PubMed ID: 20595625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inotropes.
    Francis GS; Bartos JA; Adatya S
    J Am Coll Cardiol; 2014 May; 63(20):2069-2078. PubMed ID: 24530672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Getting to the Heart of the Matter: A Regional Survey of Current Hospice Practices Caring for Patients With Heart Failure Receiving Advanced Therapies.
    Groninger H; Gilhuly D; Walker KA
    Am J Hosp Palliat Care; 2019 Jan; 36(1):55-59. PubMed ID: 30037272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study.
    Cesario D; Clark J; Maisel A
    Am Heart J; 1998 Jan; 135(1):121-9. PubMed ID: 9453531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.